These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22730859)

  • 21. Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice.
    Matte GS; Howe RJ; Ibla J; Emani S; Emani SM
    J Extra Corpor Technol; 2019 Dec; 51(4):221-226. PubMed ID: 31915405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.
    Martindale SJ; Shayevitz JR; D'Errico C
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):458-63. PubMed ID: 8776637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Characteristics in Healthy Adults and Critically Ill Patients.
    Wehner JE; Boehne M; David S; Brand K; Tiede A; Bikker R
    Clin Appl Thromb Hemost; 2020; 26():1076029620975494. PubMed ID: 33350327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron
    Hoffmann RF; Horsten S; Mariani MA; de Vries AJ
    Perfusion; 2023 Mar; 38(2):285-291. PubMed ID: 34596463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of activated coagulation time in children: evaluation of the blood-saving kaolin i-STAT activated coagulation time technique in pediatric cardiac anesthesia.
    Ulmer FF; Baulig W; Béttex D; Spielmann N; Bürki C; Weiss M
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):395-401. PubMed ID: 21376632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the heparin management test and the HemoTec activated clotting time in patients undergoing percutaneous coronary intervention.
    Tsimikas S; Beyer R; Hassankhani A
    J Thromb Thrombolysis; 2001 May; 11(3):217-21. PubMed ID: 11577260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring high-dose heparin levels by ACT and HMT during extracorporeal circulation: diagnostic accuracy of three compact monitors.
    Giavarina D; Carta M; Fabbri A; Manfredi J; Gasparotto E; Soffiati G
    Perfusion; 2002 Jan; 17(1):23-6. PubMed ID: 11817524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of heparin on three whole blood activated clotting tests and thrombin time.
    Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR
    ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements.
    Garvin S; FitzGerald DC; Despotis G; Shekar P; Body SC
    Anesth Analg; 2010 Oct; 111(4):849-55. PubMed ID: 19861367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Hemochron Response RxDx heparin and protamine dosing system.
    Jaryno SA; Zucker ML; LaDuca FM
    J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the i-STAT handheld activated clotting time with the Hemochron activated clotting time during and after percutaneous coronary intervention.
    Schussler JM; Aguanno JJ; Glover EN; Vish NA; Wissinger LA; Schumacher JR; Wheelan KR
    Am J Cardiol; 2003 Feb; 91(4):464-6. PubMed ID: 12586268
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution.
    Lee JM; Park EY; Kim KM; Won JC; Jung TK; Lee SK
    J Int Med Res; 2018 Feb; 46(2):873-882. PubMed ID: 28974132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures.
    El Rouby S; Cohen M; Gonzales A; Hoppensteadt D; Lee T; Zucker ML; Khalid K; Laduca FM; Fareed J
    J Thromb Thrombolysis; 2006 Apr; 21(2):137-45. PubMed ID: 16622609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400.
    Colby CE; Sheehan A; Benitz W; Van Meurs K; Halamek LP; Moss RL
    J Extra Corpor Technol; 2003 Mar; 35(1):35-8. PubMed ID: 12680494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole blood coagulation analyzers.
    Health Devices; 1997 Aug; 26(8):296-332. PubMed ID: 9283920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT Plus.
    Lewandrowski EL; Van Cott EM; Gregory K; Jang IK; Lewandrowski KB
    Am J Clin Pathol; 2011 May; 135(5):741-8. PubMed ID: 21502428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How does the age of a blood sample affect it's activated clotting time? Comparison of eight different devices.
    Searles B; Nasrallah F; Darling E; Yarcusko S
    J Extra Corpor Technol; 2002 Sep; 34(3):175-7. PubMed ID: 12395961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.